Rival vaccine maker Novavax (NASDAQ:NVAX) stock rose 7.0%, meanwhile, after Japan sealed a deal for 150 million doses of its Covid-19 drug. Elsewhere in the pharma world, Genmab ADRs (NASDAQ:GMAB) fell 2.2% and Amgen (NASDAQ:AMGN) stock fell 1.9% after Morgan Stanley (NYSE:MS) analysts downgraded both to Equal Weight on valuation concerns after their recent rallies. Related Articles Wall Street Falls at Open on Growth Fears; Dow Jones Down 175 Pts 5 Popular Robinhood Stocks to Buy for September Is Cinedigm a Good NFT Stock to Own?